Mizuho Raises Walgreens Boots Alliance (NASDAQ:WBA) Price Target to $47.00


Share on StockTwits

Walgreens Boots Alliance (NASDAQ:WBA) had its target price raised by Mizuho from $37.00 to $47.00 in a report released on Monday morning, The Fly reports. They currently have a neutral rating on the pharmacy operator’s stock.

WBA has been the subject of several other research reports. BidaskClub cut shares of Walgreens Boots Alliance from a hold rating to a sell rating in a report on Friday, December 18th. Truist Financial boosted their price target on shares of Walgreens Boots Alliance from $40.00 to $44.00 in a report on Tuesday, January 5th. The Goldman Sachs Group lowered their target price on shares of Walgreens Boots Alliance from $37.00 to $33.00 and set a sell rating for the company in a report on Tuesday, October 6th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a sell rating to a hold rating and set a $39.00 target price for the company in a report on Saturday, November 7th. Finally, Citigroup lowered their target price on shares of Walgreens Boots Alliance from $43.00 to $40.00 and set a neutral rating for the company in a report on Friday, October 16th. Four investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have given a buy rating to the company. Walgreens Boots Alliance currently has a consensus rating of Hold and an average price target of $44.22.

NASDAQ WBA opened at $48.94 on Monday. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 0.58. Walgreens Boots Alliance has a 52 week low of $33.36 and a 52 week high of $54.79. The stock has a market capitalization of $42.29 billion, a PE ratio of 97.88, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. The firm has a 50 day moving average of $41.34 and a two-hundred day moving average of $39.34.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, January 6th. The pharmacy operator reported $1.22 EPS for the quarter, topping the consensus estimate of $1.03 by $0.19. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The company had revenue of $36.31 billion during the quarter, compared to analysts’ expectations of $35.01 billion. During the same quarter in the previous year, the business posted $1.37 EPS. The firm’s revenue was up 5.7% on a year-over-year basis. On average, equities research analysts expect that Walgreens Boots Alliance will post 4.84 earnings per share for the current fiscal year.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 5,000 shares of the company’s stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $41.55, for a total transaction of $207,750.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 16.91% of the stock is currently owned by corporate insiders.

Large investors have recently bought and sold shares of the company. McIlrath & Eck LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth $29,000. Holloway Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth $32,000. Advisory Alpha LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth $34,000. Creative Financial Designs Inc. ADV grew its stake in shares of Walgreens Boots Alliance by 1,038.0% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 1,138 shares of the pharmacy operator’s stock worth $45,000 after purchasing an additional 1,038 shares during the period. Finally, Planned Solutions Inc. acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth $46,000. 55.96% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Featured Story: Arbitrage

The Fly

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.